INS and diabetes mellitus: Given glucose (but not fructose) rapidly elevates plasma insulin, Australian formulations may affect risk for metabolic diseases, including diabetes [18], in a manner that is distinct from high-fructose drinks, which promote lipid accumulation [21,22,23].